1-20 of 22
Toshiki Uchida, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favorable Outcomes of Newly Diagnosed Intravascular Large B-Cell Lymphoma Patients Treated with R-CHOP Combined with High-Dose Methotrexate Plus Intrathecal Chemotherapy: Results from a Multicenter Phase 2 Trial (PRIMEUR-IVL)

Kazuyuki Shimada, MD, Motoko Yamaguchi, MD PhD, Yoshiko Atsuta, MD PhD, Kosei Matsue, MD PhD, Keijiro Sato, MD, Shigeru Kusumoto, MD PhD, Hirokazu Nagai, MD PhD, Jun Takizawa, MD PhD, Noriko Fukuhara, MD PhD, Koji Nagafuji, MD PhD, Kana Miyazaki, MD PhD, Eiichi Ohtsuka, MD, Masataka Okamoto, MD PhD, Yasumasa Sugita, MD PhD, Toshiki Uchida, MD PhD, Satoshi Kayukawa, MD, Atsushi Wake, MD PhD, Daisuke Ennishi, MD PhD, Yukio Kondo, MD, Tohru Izumi, MD, Yoshihiro Kin, MD, Kunihiro Tsukasaki, MD PhD, Daigo Hashimoto, Masaaki Yuge, MD PhD, Atsumi Yanagisawa, Yachiyo Kuwatsuka, MD PhD, Satoko Shimada, MD, Yasufumi Masaki, MD PhD, Nozomi Niitsu, MD PhD, Hitoshi Kiyoi, MD PhD, Ritsuro Suzuki, MD PhD, Takashi Tokunaga, MD PhD, Shigeo Nakamura, MD, Tomohiro Kinoshita, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 350.
https://doi.org/10.1182/blood-2019-126798
Published: 2019
Journal Articles

Phase 2 Study of E7777, a Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein, in Japanese Patients with Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphoma

Dai Maruyama, MD PhD, Kiyoshi Ando, Kazuhito Yamamoto, Eiji Kiyohara, MD, Yasuhito Terui, MD PhD, Noriko Fukuhara, MD PhD, Tomomitsu Miyagaki, MD PhD, Hidetsugu Kawai, MD, Yoshiki Tokura, MD PhD, Mamiko Sakata-Yanagimoto, MD PhD, Tadahiko Igarashi, MD PhD, Junya Kuroda, MD PhD, Jiro Fujita, MD PhD, Toshiki Uchida, MD PhD, Takayuki Ishikawa, MD PhD, Kentaro Yonekura, MD PhD, Koji Kato, MD PhD, Tadashi Nakanishi, Kenya Nakai, Risa Matsunaga, Kensei Tobinai, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4032.
https://doi.org/10.1182/blood-2019-121723
Published: 2019
Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Nobuhiko Yamauchi, Dai Maruyama, MD PhD, Ilseung Choi, MD PhD, Yoshiko Atsuta, MD PhD, Hirotaka Takasaki, MD PhD, Kazuho Miyashita, MD PhD, Yukiyoshi Moriuchi, MD, Hideki Tsujimura, MD PhD, Nobuko Kubota, MD PhD, Go Yamamoto, MD PhD, Tadahiko Igarashi, MD PhD, Koji Izutsu, MDPhD, Shinichiro Yoshida, MD PhD, Kensuke Kojima, MD PhD, Toshiki Uchida, MD PhD, Yoshiko Inoue, MD, Norifumi Tsukamoto, MD PhD, Eiichi Ohtsuka, MD PhD, Sachiko Suzuki, MD PhD, Yoko Inaguma, MD PhD, Satoshi Ichikawa, MD, Hiroshi Gomyo, MD, Yoko Ushijima, MD PhD, Kisato Nosaka, MD PhD, Mio Kurata, Yasuhito Tanaka, MD PhD, Ryuzo Ueda, MD PhD, Masashi Mizokami, MD PhD, Shigeru Kusumoto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4209.
https://doi.org/10.1182/blood-2018-99-114850
Published: 2018
Journal Articles

Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601

Ken Ohmachi, MD, Tomohiro Kinoshita, MD PhD, Kensei Tobinai, MD PhD, Gakuto Ogawa, MD PhD, Tomonori Mizutani, MD PhD, Nobuhiko Yamauchi, MD, Noriko Fukuhara, MD PhD, Toshiki Uchida, MD PhD, Kazuhito Yamamoto, MD PhD, Kana Miyazaki, MD PhD, Norifumi Tsukamoto, MD PhD, Shinsuke Iida, MD PhD, Takahiko Utsumi, MD PhD, Isao Yoshida, MD PhD, Yoshitaka Imaizumi, MD, PhD, Takashi Tokunaga, MD PhD, Shinichiro Yoshida, MD PhD, Yasufumi Masaki, MD PhD, Tohru Murayama, MD PhD, Yoshihiro Yakushijin, MD PhD, Youko Suehiro, MD PhD, Kisato Nosaka, MD PhD, Nobuaki Dobashi, MD, Junya Kuroda, MD PhD, Yasushi Takamatsu, MD PhD, Dai Maruyama, MD PhD, Kiyoshi Ando, MD PhD, Kenichi Ishizawa, MD PhD, Michinori Ogura, MD PhD, Tadashi Yoshino, MD PhD, Tomomitsu Hotta, MD PhD, Kunihiro Tsukasaki, MD PhD, Hirokazu Nagai, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4194.
https://doi.org/10.1182/blood-2018-99-110201
Published: 2018
Journal Articles

Updated Report of a Phase I/II Multicenter Study of Forodesine, a Purine Nucleoside Phosphorylase Inhibitor, in Japanese Patients with Relapsed Peripheral T-Cell Lymphoma

Hirohiko Shibayama, MD PhD, Kensei Tobinai, MD PhD, Kunihiro Tsukasaki, MD PhD, Toshiki Uchida, MD PhD, Yoshinobu Maeda, MDPhD, Hirokazu Nagai, MD PhD, Mitsutoshi Kurosawa, MD PhD, Youko Suehiro, MD, Kiyohiko Hatake, MD PhD, Kiyoshi Ando, MD PhD, Isao Yoshida, MD PhD, Michihiro Hidaka, MD PhD, Tohru Murayama, MD PhD, Yoko Okitsu, MD PhD, Norifumi Tsukamoto, MDPhDChief Division, Masafumi Taniwaki, MD PhD, Junji Suzumiya, MD PhD, Kazuo Tamura, MD PhD, Takahiro Yamauchi, MD PhD, Ryuzo Ueda, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4075.
https://doi.org/10.1182/blood.V130.Suppl_1.4075.4075
Published: 2017
Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Yoshitoyo Kagami, MD, Kazuhito Yamamoto, MDPhD, Taro Shibata, MSc, Kensei Tobinai, MD PhD, Yoshitaka Imaizumi, MD PhD, Toshiki Uchida, MD PhD, Kazuyuki Shimada, MD, Koichiro Minauchi, MD, Noriko Fukuhara, MD PhD, Hirofumi Kobayashi, MD PhD, Nobuhiko Yamauchi, MD, Hideki Tsujimura, MD PhD, Akira Hangaishi, MD, Ryo Tominaga, MD, Youko Suehiro, MD, Shinichiro Yoshida, MD PhD, Yoshiko Inoue, MD, Sachiko Suzuki, MD, Michihide Tokuhira, MD, Hirokazu Nagai, MD PhD, Shigeru Kusumoto, MD, Junya Kuroda, MD PhD, Yoshihiro Yakushijin, MD PhD, Yasushi Takamatsu, MD PhD, Yasushi Kubota, MD PhD, Kisato Nosaka, MD, Satoko Morishima, MD PhD, Shigeo Nakamura, MD PhD, Dai Maruyama, MD PhD, Tomomitsu Hotta, MD, Yasuo Morishima, MD PhD, Kunihiro Tsukasaki, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4127.
https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127
Published: 2017
Journal Articles

Safety, Efficacy, and Pharmacokinetic Profiles of Intravenous Rigosertib in Japanese Patients with Recurrent/Relapsed or Refractory Myelodysplastic Syndromes: A Multicenter, Open-Label Phase I Clinical Study

Michinori Ogura, Yukio Kobayashi, MD PhD, Shiro Kubonishi, MD PhD, Michihiro Hidaka, MD PhD, Toshiki Uchida, MD PhD, Yasushi Takamatsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5549.
https://doi.org/10.1182/blood.V128.22.5549.5549
Published: 2016
Journal Articles

Phase I/II Multicenter Study of Romidepsin in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Michinori Ogura, Dai Maruyama, MD PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD PhD, Kiyohiko Hatake, MD PhD, Masafumi Taniwaki, MD PhD, Kiyoshi Ando, MD PhD, Kunihiro Tsukasaki, MD, Takashi Ishida, MD PhD, Naoki Kobayashi, MD PhD, Kenichi Ishizawa, MD PhD, Yoichi Tatsumi, Koji Kato, MD PhD, Toru Kiguchi, MD PhD, Takayuki Ikezoe, MD PhD, Eric Laille, MS, Tokihiro Ro, MS, Hiromi Tamakoshi, MBA, Sanae Sakurai, MS, Tomoko Ohtsu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3012.
https://doi.org/10.1182/blood.V128.22.3012.3012
Published: 2016
Journal Articles

Phase I Study of E7777, a Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein, in Japanese Patients with Relapsed or Refractory Peripheral and Cutaneous T-Cell Lymphoma

Dai Maruyama, MD PhD, Kensei Tobinai, MD PhD, Kiyoshi Ando, MD PhD, Ken Ohmachi, MD, Michinori Ogura, MD PhD, Toshiki Uchida, MD PhD, Tadashi Nakanishi, Masayuki Namiki, PhD
Journal: Blood
Blood (2015) 126 (23): 2724.
https://doi.org/10.1182/blood.V126.23.2724.2724
Published: 2015
Journal Articles

A Phase 1/2 Study of WT1 Peptide Cancer Vaccine WT4869 in Patients with Myelodysplastic Syndromes (MDS)

Takahiro Suzuki, MD PhD, Yasunori Ueda, MD PhD, Michinori Ogura, MD PhD, Toshiki Uchida, MD PhD, Keiya Ozawa, MD PhD, Shigesaburo Miyakoshi, MDPhD, Tomoki Naoe, MD PhD, Makoto Murata, MD PhD, Masahiro Kizaki, MD PhD, Naokuni Uike, MD, Yasunobu Abe, MD PhD, Michihiro Hidaka, MD PhD, Shuzo Tagashira, Satoru Tsuchiya, Kazuma Ohyashiki, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2868.
https://doi.org/10.1182/blood.V126.23.2868.2868
Published: 2015
Journal Articles

Two Phase I and Pharmacokinetic Studies of Darinaparsin (Organic Arsenic Compound) in Japanese and Korean Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)

Won-Seog Kim, MD PhD, Michinori Ogura, MD PhD, Toshiki Uchida, MD PhD, Naokuni Uike, MD, PhD, Yasunobu Abe, MD PhD, Kenichi Ishizawa, MD, PhD, Yoko Okitsu, MD PhD, Kensei Tobinai, MD PhD, Fumiko Nagahama, Yusuke Sonehara, Hirokazu Nagai, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2714.
https://doi.org/10.1182/blood.V126.23.2714.2714
Published: 2015
Journal Articles

Phase 2 Study of Lenalidomide in Combination with Low-Dose Dexamethasone in Japanese Transplantation-Ineligible Newly-Diagnosed Multiple Myeloma Patients

Takaaki Chou, Atsushi Shinagawa, MD PhD, Toshiki Uchida, MD, Masafumi Taniwaki, MD PhD, Hirokazu Hirata, MD PhD, Kenichi Ishizawa, MD PhD, Kosei Matsue, MD PhD, Yoshiaki Ogawa, MD, Takayuki Shimizu, MD PhD, Maki Otsuka, MD, Morio Matsumoto, MD, Shinsuke Iida, Yasuhito Terui, MD PhD, Itaru Matsumura, Takashi Ikeda, MD PhD, Naoki Takezako, MD PhD, Yumi Ogaki, MD, Shuichi Midorikawa, MD, Vanessa Houck, Annette Ervin-Haynes, Kenshi Suzuki, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3452.
https://doi.org/10.1182/blood.V124.21.3452.3452
Published: 2014
Journal Articles

A Multicenter Phase I Study of the Humanized Anti-CD19 Monoclonal Antibody, MEDI-551, in Patients with Relapsed or Refractory B-Cell Lymphoma and Multiple Myeloma

Michinori Ogura, MD PhD, Kiyoshi Ando, MD, Naokuni Uike, Yoshiaki Ogawa, MD, Toshiki Uchida, MD, Yasunobu Abe, MD, Takanobu Morishita, MD, Minoru Kojima, MD PhD, Ilseung Choi, MD, Katsuro Yagawa, MD, Yuki Yokoi, Jun Okamura, MD
Journal: Blood
Blood (2014) 124 (21): 1756.
https://doi.org/10.1182/blood.V124.21.1756.1756
Published: 2014
Journal Articles

Simplified MIPI Is a Valid Prognostic Index In The Rituximab Era: Multicenter MCL Study In Japan

Dai Chihara, MD, PhD, Naoko Asano, MD, Ph.D., Tomohiro Kinoshita, MD, PhD, Yoshinobu Maeda, MD, PhD, Kosei Matsue, MD, PhD, Ken Ohmachi, M.D., Masataka Okamoto, MD, PhD, Ishikazu Mizuno, MD, Toshiki Uchida, MD, PhD, Hirokazu Nagai, MD, PhD, Michinori Ogura, M.D., Ph.D., Ritsuro Suzuki, MD
Journal: Blood
Blood (2013) 122 (21): 4257.
https://doi.org/10.1182/blood.V122.21.4257.4257
Published: 2013
Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2641.
https://doi.org/10.1182/blood.V120.21.2641.2641
Published: 2012
Journal Articles

A Clinical Pharmacology and Exploratory Study of Azacitidine Administered Subcutaneously or Intravenously In Japanese Patients with Myelodysplastic Syndrome

Yukio Kobayashi, MD, PhD, Michinori Ogura, MD, PhD, Kiyoshi Ando, MD, PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD, PhD, Yoshiaki Ogawa, MD, PhD, Takayuki Ishikawa, MD, PhD, Haruhiko Ohashi, MD, PhD, Tomoko Hata, MD, PhD, Noriko Usui, MD, PhD, Masafumi Taniwaki, MD, PhD, Kazunori Ohnishi, MD, PhD, Hideki Akiyama, MD, PhD, Keiya Ozawa, MD, PhD, Kazuma Ohyashiki, MD, PhD, Shinichiro Okamoto, MD, PhD, Akihiro Tomita, MD, PhD, Shinji Nakao, MD, PhD, Tomomitsu Hotta, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4964.
https://doi.org/10.1182/blood.V116.21.4964.4964
Published: 2010
Journal Articles

Durable Responses with Bendamustine Monotherapy In Patients with Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle-Cell Lymphoma (MCL): Updated Follow-up Data From a Japanese Multicenter Phase II Study

Kuniaki Itoh, MD, PhD, Kiyoshi Ando, MD, PhD, Michinori Ogura, MD, PhD, Kenichi Ishizawa, MD, PhD, Takashi Watanabe, MD, PhD, Naokuni Uike, MD, PhD, Yasuhito Terui, MD, PhD, Kensuke Usuki, MD, PhD, Hirokazu Nagai, MD, PhD, Nobuhiko Uoshima, MD, PhD, Nobuko Kubota, MD, PhD, Ken Ohmachi, MD, PhD, Toshiki Uchida, MD, PhD, Joji Yamamoto, MD, PhD, Ilseung Choi, MD, PhD, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4884.
https://doi.org/10.1182/blood.V116.21.4884.4884
Published: 2010
Journal Articles

Phase I Study of a New Humanized Anti-CD20 Monoclonal Antibody (LY2469298) in Japanese Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Pretreated with Rituximab-Containing Regimen

Michinori Ogura, MD, PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD, PhD, Yukio Kobayashi, MD, PhD, Takashi Oyama, MD, Takashi Watanabe, MD, PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD, PhD, Masanobu Kasai, MD, Masakazu Mori, MD, Tomomi Matsue, Damien Cronier, PhD, James E Wooldridge, MD, Minori Koshiji, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3942.
https://doi.org/10.1182/blood.V116.21.3942.3942
Published: 2010
Journal Articles

Phase I and Pharmacokinetic (PK) Study of Everolimus (RAD001) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL).

Michinori Ogura, MD, PhD, Toshiki Uchida, MD, PhD, Dai Maruyama, MD, PhD, Naokuni Uike, MD, PhD, IIseung Choi, MD, PhD, Kenichi Ishizawa, MD, PhD, Kuniaki Itoh, MD, PhD, Kiyoshi Ando, MD, PhD, Masafumi Taniwaki, MD, PhD, Naomi Shimada, Ken Kobayashi, MD, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1712.
https://doi.org/10.1182/blood.V114.22.1712.1712
Published: 2009
Journal Articles

Bendamustine Is Highly Effective for Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mantle Cell Lymphoma (MCL): Final Results of a Japanese Multicenter Phase II Study.

Michinori Ogura, MD, PhD, Toshiki Uchida, MD, PhD, Kiyoshi Ando, MD, PhD, Ken Ohmachi, MD, PhD, Kuniaki Itoh, MD, PhD, Nobuko Kubota, MD, PhD, Kenichi Ishizawa, MD, PhD, Joji Yamamoto, MD, PhD, Takashi Watanabe, MD, PhD, Naokuni Uike, MD, PhD, IIseung Choi, MD, PhD, Yasuhito Terui, MD, PhD, Kensuke Usuki, MD, PhD, Hirokazu Nagai, MD, PhD, Nobuhiko Uoshima, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3694.
https://doi.org/10.1182/blood.V114.22.3694.3694
Published: 2009